The Patent Finder

Fulvestrant formulations

Eagle Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 61/068,560, filed Mar 7, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,801,892Fulvestrant Formulations
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 10,363,259Fulvestrant Formulations
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
US 9,180,088Fulvestrant formulations
In force
 · High confidence
Eagle Pharmaceuticals, Inc.In force
High confidence
Application 16/508,741Fulvestrant Formulations
Abandoned
Abandoned Sep 22, 2020
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Sep 22, 2020
Application 17/022,574Fulvestrant Formulations
Abandoned
Abandoned Sep 24, 2022
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Sep 24, 2022
Application 17/819,726Fulvestrant Formulations
Abandoned
Abandoned Nov 17, 2023
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Nov 17, 2023
Application 18/506,633Fulvestrant Formulations
Abandoned
Abandoned Dec 11, 2024
Eagle Pharmaceuticals, Inc.AbandonedAbandoned Dec 11, 2024
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Eagle Pharmaceuticals, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited